byiShook Opinion
Jan 27, 2025 - 10:50
Akero Therapeutics doubled Monday — and pulled 89bio shares higher — after the company's treatment for MASH obliterated expectations. The post Akero Therapeutics Stock Doubles — Pulling 89bio Higher — On Positive MASH Study appeared first on Investor's Business Daily.
Akero Therapeutics doubled Monday â and pulled 89bio shares higher â after the company's treatment for MASH obliterated expectations.
The post Akero Therapeutics Stock Doubles â Pulling 89bio Higher â On Positive MASH Study appeared first on Investor's Business Daily.